Executive Chairman and Chief Executive Officer
2002 – 2008 COO President and CEO of Valeant Pharmaceuticals International
- Achieved a growth in sales of 69% and earnings increase of 135%
- Led a major re-structuring of the company
- Established a highly effective R&D capability which developed a best-in-class epilepsy compound and a promising pro-drug for hepatitis C, both in Phase III
1988 – 2002 Corporate Executive Team for GlaxoSmithKline
- President, Global Manufacturing & Supply and ran Glaxo Dermatology and Cerenex Pharmaceuticals
- Managed all Sales and Marketing for GlaxoWellcome’s US operations, launching 32 products, eight of which achieved sales of greater than $1billion
1980 – 1988 Executive Positions at Bristol Myers
- Responsible for Commercial, Technical Operations and R&D
Other Achievements
- Manufacturing Manager for Proctor and Gamble
- Graduated from the United States Military Academy at West Point in 1974 and served on active duty as an officer in the United States Army from 1974 – 1979
- Achieved a Master of Public Administration in 1976 and Master of Business Administration in 1979 from Jacksonville State University whilst on active duty
- Has also served on the board of directors for:
- Pharmaceutical Research and Manufacturing Association (PhRMA);
- BICOM;
- CEO Roundtable for the University of California at Irvine
- Dean’s Executive Forum at Cal State Fullerton;
- CEO Council on Cancer;
- Health Sector Advisory Board at Duke University;
- Leadership Forum of the International Society of Pharmaceutical Engineers and as a visiting lecturer at Cambridge University;
- Non-profit organizations in Raleigh-Durham, NC and Orange County, CA and with the United Way.